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We investigated the role of reactive oxygen species (ROS) and nitric oxide (NO) in ethanol-induced relaxa-
tion. Vascular reactivity experiments showed that ethanol (0.03–200 mmol/L) induced relaxation in
endothelium-intact and denuded rat aortic rings isolated from male Wistar rats. Pre-incubation of intact or
denuded rings with L-NAME (non selective NOS inhibitor, 100 μmol/L), 7-nitroindazole (selective nNOS in-
hibitor, 100 μmol/L), ODQ (selective inhibitor of guanylyl cyclase enzyme, 1 μmol/L), glibenclamide (selective
blocker of ATP-sensitive K+ channels, 3 μmol/L) and 4-aminopyridine (selective blocker of voltage-
dependent K+ channels, 4-AP, 1 mmol/L) reduced ethanol-induced relaxation. Similarly, tiron (superoxide
anion (O2−) scavenger, 1 mmol/L) and catalase (hydrogen peroxide (H2O2) scavenger, 300 U/mL) reduced
ethanol-induced relaxation to a similar extent in both endothelium-intact and denuded rings. Finally, prodi-
fen (non-selective cytochrome P450 enzymes inhibitor, 10 μmol/L) and 4-methylpyrazole (selective alcohol
dehydrogenase inhibitor, 10 μmol/L) reduced ethanol-induced relaxation. In cultured aortic vascular smooth
muscle cells (VSMCs), ethanol stimulated generation of NO, which was signiﬁcantly inhibited by L-NAME. In
endothelial cells, ﬂow cytometry studies showed that ethanol increased cytosolic Ca2+ concentration ([Ca2
+]c), O2- and cytosolic NO concentration ([NO]c). Tiron inhibited ethanol-induced increase in [Ca2+]c and
[NO]c. The major new ﬁnding of this work is that ethanol induces relaxation via redox-sensitive and NO–
cGMP-dependent pathways through direct effects on ROS production and NO signaling. These ﬁndings iden-
tify putative molecular mechanisms whereby ethanol, at pharmacological concentrations, inﬂuences vascular
reactivity.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
The relationship between ethanol consumption and blood
pressure is complex. Chronic consumption of high doses of ethanol
is associated with hypertension in animals and humans
(Wakabayashi, 2008; Tirapelli et al., 2008). On the other hand,
consumption of low to moderate amounts of ethanol has been
described to exert beneﬁcial effects on the cardiovascular system.
For example, chronic consumption of low doses of ethanol is effective
in decreasing blood pressure in rat models of hypertension (Vasdev et
al., 2006). Ethanol consumption was also described to reduce the risk
of myocardial infarction in hypertensive patients (Beulens et al.,
2007). Moreover, the inverse correlation between moderate ethanol
intake and coronary mortality has long been recognized (Albert et
al., 1999; Klatsky, 2002).
Vascular relaxation might explain, at least in part, the beneﬁcial
effects of moderate ethanol consumption on the cardiovascular sys-
tem. Arterial dilatation accompanied by hypotension is observed in
the ﬁrst hours after consumption of ethanol (Abe et al., 1994; Rosito
et al., 1999; Bau et al., 2005). In vitro studies using isolated tissues
show that ethanol induces direct relaxant responses in different
blood vessels (Greenberg et al., 1993; Ru et al., 2008). Ethanol-
induced vascular relaxation is related to the synthesis and action of
endothelial factors, such as nitric oxide (NO) (Greenberg et al.,
1993; Puddey et al., 2001), and prostaglandin (Greenberg et al.,
1993). In fact, the beneﬁcial effect of low ethanol doses on the
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cardiovascular system has been related to the release of NO (Puddey
et al., 2001). Ethanol increases the expression of eNOS (Venkov et al.,
1999) and stimulated Ca2+-activated potassium channels increasing
production of NO in cultured vascular endothelial cells (Kuhlmann
et al., 2004). Moreover, ethanol relaxes bovine pulmonary arteries
through enhancement of both basal and stimulated release of NO
(Greenberg et al., 1993). Interestingly, the relaxation induced by eth-
anol is not completely abolished after endothelial removal, suggesting
that this response is partially mediated by vascular smooth muscle
cells (VSMC) (Greenberg et al., 1993; Ru et al., 2008).
The effect of ethanol on the vasculature is complex. Although eth-
anol is primarily metabolized in the liver, it is also metabolized in
other tissues, including the vascular tissue. Ethanol-metabolizing en-
zymes alcohol dehydrogenase (ADH) and cytochrome P450-2E1
(CYP-2E1) are functionally active in the vasculature, and ethanol me-
tabolism in this tissue leads to oxidative stress and the generation of
reactive oxygen species (ROS) (Haorah et al., 2005). Superoxide anion
(O2−) and hydrogen peroxide (H2O2) are two of the most important
ROS in the vessel wall (Touyz, 2000; Touyz and Schiffrin, 2004). Stud-
ies in endothelial cells have shown that O2− induces a rapid rise in cy-
tosolic concentration of Ca2+ ([Ca2+]c) (Franceschi et al., 1990;
Dreher and Junot, 1995; Hirosumi et al., 1988), which activates endo-
thelial NO synthase (eNOS) with consequent vasorelaxation (Duarte
et al., 2004). Superoxide anion is reduced by superoxide dismutase
to H2O2 (Touyz and Schiffrin, 2004), which is implicated in the regu-
lation of signaling pathways that leads to vascular relaxation (Barlow
and White, 1998a, 1998b; Barlow et al., 2000). Moreover, H2O2 is
known to activate phospholipase A2 (PLA2) (Rao et al., 1995; Boyer
et al., 1995), resulting in the stimulation of arachidonic acid release
(Sporn et al., 1992; Boyer et al., 1995) and increase in [Ca2+]c
(Suzuki et al., 1997). Recently, we provided evidence that ethanol in-
creases the generation of O2− and H2O2 in aortic smooth muscle cells
and that ethanol-induced increase of [Ca2+]c in these cells is attenu-
ated by ROS scavengers and cyclooxygenase inhibitors (Yogi et al.,
2010). Our results show that ethanol stimulates ROS generation,
which in turn may lead to production of prostanoids that induce in-
crease of [Ca2+]c. However, whether ethanol-induced NO generation
and relaxation is modulated by ROS remains to be determined.
Since ethanol may have both protective and harmful effects in the
cardiovascular system, the identiﬁcation of biochemical mechanisms
that could explain such paradoxical effects is warranted. Based on
the above mentioned observations, we hypothesized that the relaxant
effect of ethanol involves the generation of ROS and activation of NOS
in the vasculature. To test this hypothesis the present study has
attempted to investigate the role played by ROS in ethanol-induced
relaxation and NO generation, thereby giving us some insight into
the potential contribution of these cellular-signaling pathways to
ethanol-induced vasorelaxation.
2. Material and methods
2.1. Vascular reactivity studies
Male Wistar rats weighting between 200 and 250 g (50–60 days
old) were anesthetized and killed by aortic exsanguination in accor-
dance to standards and policies of the University of São Paulo's Ani-
mal Care and Use Committee. The thoracic aorta was quickly
removed, cleaned of adherent connective tissues and cut into rings
(5–6 mm in length). Two stainless-steel stirrups were passed through
the lumen of each ring. One stirrup was connected to an isometric
force transducer TRI201 (Panlab, Spain) to measure tension in the
vessels. The rings were placed in a 5 mL organ chamber containing
Krebs solution, pH 7.4, gassed with 95%O2/5%CO2, and maintained at
37 °C. The composition of Krebs solution was as follows (mmol/L):
NaCl, 118.0; KCl, 4.7; KH2PO4, 1.2; MgSO4, 1.2; NaHCO3, 15.0; Glucose,
5.5; and CaCl2, 2.5. The rings were stretched until they reached a basal
tension of 1.5 g, as determined by length-tension relationship exper-
iments and were then allowed to equilibrate for 60 min; during this
time, the bath ﬂuid was changed every 15–20 min. For some rings,
the endothelium was removed mechanically by gently rolling the
vessel lumen on a thin wire. Endothelial integrity was assessed qual-
itatively by the degree of relaxation induced by acetylcholine
(1 μmol/L) in the presence of contractile tone induced by phenyleph-
rine (0.1 μmol/L). For studies of endothelium-intact vessels, a ring
was discarded if relaxation with acetylcholine was not 80% or greater.
For studies of endothelium-denuded vessels, a ring was discarded if
there was any degree of relaxation.
2.2. Effects of ethanol on vascular reactivity
Steady tension was evoked by phenylephrine (concentrations of
0.1 μmol/L for endothelium-intact rings and 0.03 μmol/L for
endothelium-denuded rings were used to induce contractions of sim-
ilar magnitude) and ethanol was then added in a stepwise fashion
(0.03–200 mmol/L). Additions of ethanol were made as soon as a
steady response was obtained at the preceding concentration. The
concentration of ethanol used in our work was based on previous
studies in different type of blood vessels (Greenberg et al., 1993;
Hendrickson et al., 1999; Ru et al., 2008). In the present investigation
we used concentrations of ethanol that are well within those de-
scribed in the bloodstream of humans (Kalant, 1971) and rats
(Husain et al., 2005; Tirapelli et al., 2008) after ethanol ingestion.
For comparison, the effect of acetylcholine (10 nmol/L to10 μmol/L)
and sodium nitroprusside (SNP, 10 nmol/L–0.1 μmol/L), were also
evaluated in endothelium-intact and -denuded rings, respectively.
The mechanisms underlying the relaxant effect induced by etha-
nol were studied in endothelium-intact and endothelium-denuded
rings pre-incubated for 30 min with the following drugs: NG-nitro-L-
arginine-methyl-ester (L-NAME, non-selective NO synthase inhibitor,
100 μmol/L), 7-nitroindazole (selective nNOS inhibitor, 100 μmol/L),
wortmannin (PI3K inhibitor, 0.5 μmol/L), indomethacin (non-selec-
tive cyclooxygenase inhibitor, 10 μmol/L), 1H-[1,2,4]oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ, selective guanylyl cyclase inhibitor,
1 μmol/L), tiron (O2− scavenger, 1 mmol/L), catalase (H2O2 scavenger,
300 U/mL), prodifen (non-selective cytochrome P450 enzymes inhib-
itor, 10 μmol/L), apocynin (NADPH inhibitor, 100 μmol/L) and 4-
methylpyrazole (selective ADH inhibitor, 10 μmol/L). The participa-
tion of K+ channels on ethanol-induced relaxation was investigated
using the following inhibitors: apamin (selective blocker of low-
conductance Ca2+-activated channels, 1 μmol/L), glibenclamide (se-
lective blocker of ATP-sensitive K+ channels, 3 μmol/L), charybdo-
toxin (selective blocker of large-conductance Ca2+-activated K+
channels, 0.1 μmol/L) and 4-aminopyridine (selective blocker of
voltage-dependent K+ channels, 4-AP, 1 mmol/L), which were used
as described by Nelson and Quayle (1995). In some protocols, combi-
nations of these drugs were used. Relaxation was expressed as per-
centage change from the phenylephrine-contracted levels. Because
L-NAME and ODQ enhanced phenylephrine-induced contraction, the
rings with intact endothelium exposed to these compounds were
pre-contracted with phenylephrine 0.03 μmol/L, to induce a magni-
tude of contraction similar to that found in the intact rings not ex-
posed to the inhibitors. Concentration–response curves were ﬁtted
using a nonlinear interactive ﬁtting program (Graph Pad Prism 3.0;
GraphPad Software Inc., San Diego, CA). The potency and maximum
response are expressed as pD2 (negative logarithm of the molar con-
centration of the drug producing 50% of the maximum response) and
Emax (maximum effect), respectively.
2.3. Detection of NO in cultured VSMCs
VSMCs from aorta of Wistar–Kyoto rats were examined. Cells were
maintained in DMEM containing 10% fetal bovine serum (FBS). Low
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passaged cells (passages 2–7) were studied. The study was approved
by the Animal Ethics Committee of the University of Ottawa and per-
formed according to recommendations of the Canadian Council for
Animal Care. Adult male Wistar–Kyoto rats were euthanized by de-
capitation. VSMCs derived from aorta were isolated and characterized
as described in detail previously (Callera et al., 2005). In brief, arteries
were cleaned of adipose and connective tissue, and VSMCs were dis-
sociated by digestion of vascular arcades with enzymatic solution
(collagenase, elastase, soybean trypsin inhibitor, and bovine serum
albumin type I; 60 min, 37 °C). The tissue was ﬁltered and the cell
suspension centrifuged and resuspended in Dulbecco's modiﬁed
Eagle's medium containing 10% fetal calf serum, 2 mmol/L glutamine,
20 mmol/L HEPES (pH 7.4), and antibiotics. At subconﬂuence, the cul-
ture medium was replaced with serum-free medium for 24 h to ren-
der the cells quiescent. Low-passage cells (passages 4 to 7), from at
least 4 different primary cell cultures, were used in the experiments.
Production of NOwas determined using the NO-speciﬁc ﬂuorescent
4-Amino-5-methylamino-2′,7′-diﬂuorescein, Diaminoﬂuorescein-FM
(DAF-2 FM, Sigma, St Louis, MO, USA). Cells were loaded with DAF-2
FM (ﬁnal concentration 5 μmol/L, 30 min, 37 °C), kept in the dark, and
maintained at 37 °C. Cells were then stimulated with ethanol
(100 mmol/L) for 10 min. Because NOS generates O2− instead of NO
in the absence of L-arginine (Xia et al., 1998), we added 100 μmol/L
of L-arginine (Nakatsubo et al., 1998) to all solutions used for NO mea-
surement, except for the experiment with L-NAME-treated cells,
where L-NAME (100 μmol/L) was added 30 min before the stimulation
with ethanol. Exposure to lightwas avoided as far as possible in all sam-
ples due to light sensitivity of the ﬂuorescent probe. Subsequently the
probe was washed out with PBS and cells were harvested with mild
trypsinization. PBS (10 mL, 37 °C) was added to the cells, which were
centrifuged for 3 min at 1200 rpm. The supernatants were discarded
and the pellets were resuspended in PBS (200 μL), which were trans-
ferred to black microplates. DAF-FM nitrosation was assessed spectro-
ﬂuorometrically at excitation/emission wavelengths of 495/515 nm
(Cary Eclipse, Varian Canada, Inc). The ﬂuorescence intensity was ad-
justed to the protein concentration and expressed as ﬂuorescence
emission permicrograms of protein. Protein concentrationswere deter-
mined with protein assay reagent (Bio-Rad Laboratories).
2.4. Visualization of NO generation by intact VSMCs detectedwith ﬂuorescent
dye 4-Amino-5-methylamino-2′,7′-diﬂuorescein, Diaminoﬂuorescein-FM
(DAF-2 FM)
Generation of intracellular NO in living cells was measured with
the ﬂuoroprobe DAF-2 FM (excitation at 495 nm and emission at
515 nm). Growth-arrested VSMCs from WKY rats were incubated in
Hank's balanced salt solution (HBSS) containing 1.3 mmol/L CaCl2
and 5.5 mmol/L glucose supplemented with 5 μmol/L DAF-2 FM in a
light protected chamber at 37 °C, for 10 min. Cells were rinsed in
HBSS and images were obtained before and after cells exposition to
100 mmol/L ethanol. Cells were imaged on a wide ﬁeld epiﬂuores-
cence microscope equipped with 40× oil immersion lens using the
Stallion live-cell Digital Hi-Speed Multi-Channel Imaging System
(Zeiss, Germany).
2.5. Flow cytometry for measurement of Ca2+, NO and O2
− in endothelial
cells
Flow cytometry was performed as previously described
(Bonaventura et al., 2008). The aortas were isolated and longitudinal-
ly opened. Endothelial cells were isolated from the vessels mechani-
cally, by gently friction with plastic stem in plates containing Krebs
solution. The cells suspension was centrifuged at 1000 rpm for
5 min. The cells pellet was suspended in 1.0 mL of Krebs solution
and maintained in a humidiﬁed incubator (37 °C) until the use. Part
of this cells suspension was used for viability test. Cells viability was
determined by trypan blue staining (2%). The number of viable cells
before the isolation was estimated for each animal by counting in a
Neubauer chamber (Weber Scientiﬁc International, Germany). Cyto-
ﬂuorographic analysis was performed using a Becton–Dickinson
FACScan (San Jose, CA, USA) with an argon ion laser tuned to
488 nm at 15 mW output. The cells were analyzed at the ﬂow cyt-
ometer in the absence of the ﬂuorescent dyes. Before the detection
of [Ca2+]c, cytoplasmatic concentration of NO ([NO]c) or O2−, the
cells without the dyes were analyzed on the ﬂow cytometer
(Blank). After that, the cells were incubated with a selective ﬂuores-
cent dye for Ca2+ (Fluo-3AM, 10 μmol/L), NO (4,5-diaminoﬂuores-
cein-2 diacetate — DAF-2/DA, 10 μmol/L) or O2− (dihydroethidium —
DHE, 2 μmol/L) for 20 min. Afterwards, ethanol (1, 10 or 100 mmol/
L) was added to the cells loaded with one of the selective dyes.
After the addition of ethanol, the samples were analyzed for 10 min
in intervals of 1 min. Acquisition was set at 10,000 cells and the
mean ﬂuorescent intensity was measured in all the samples by
using CellQuest 1.2 software (Becton–Dickinson, Franklin Lakes, NJ,
Fig. 1. (A) Original traces of the isometric tension recording of endothelium-intact
(Endo+) or endothelium-denuded (Endo−) rat aortic rings in response to ethanol.
(B) Concentration–response curves for ethanol in endothelium-intact and
endothelium-denuded rat aortic rings. Endothelium-intact and -denuded rings were
pre-contracted with phenylephrine (0.1 and 0.03 μmol/L, respectively). After reaching
a stable and sustainable contraction, ethanol (0.03–200 mmol/L) was added cumula-
tively to the organ bath.
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USA). The initial ﬂuorescence intensity value was designated F0 and
the ﬁnal ﬂuorescence intensity value obtained after stimulation for
10 min with ethanol was designated F. In this way, the percentage
of the difference in ﬂuorescence intensity (%ΔFI), which reﬂects the
increase of [Ca2+]c, [NO]c or O2−, was obtained for each protocol in
relation to F (100%). It was calculated by the following formula:
%ΔFI=(F−F0/F)×100. Control responses were obtained in experi-
ments where ethanol was replaced by the vehicle (Hank's solution)
(Rodrigues et al., 2010).
In order to investigate the mechanisms underlying ethanol-
induced increase in [Ca2+]c, endothelial cells were incubated for
30 min with one of the following inhibitors: tiron (1 mmol/L), indo-
methacin (10 μmol/L) or verapamil (Ca2+ channel blocker, 10 μmol/
L). The cells were loaded with Fluo-3AM and exposed to ethanol
(100 mmol/L). In order to investigate the mechanisms underlying
ethanol-induced increase in [NO]c, endothelial cells were incubated
for 30 min with one of the following inhibitors: tiron (1 mmol/L),
indomethacin (10 μmol/L), verapamil (10 μmol/L) or L-NAME
(100 μmol/L). The cells were loaded with DAF-2/DA and exposed to
ethanol (100 mmol/L).
2.6. Drugs
ODQ, indomethacin and wortmannin were prepared as stock solu-
tions in dimethyl sulfoxide (DMSO). The other drugs were dissolved
in distilled water. The concentration of DMSO did not exceed 0.5%,
which was shown to have no effects per se on the ﬂow cytometry ex-
periments or on the functional assays.
2.7. Statistics
Statistically signiﬁcant differences were calculated by Student's t
test or one-way analysis of variance (ANOVA) followed by Newman–
Fig. 2. Effect of L-NAME, ODQ, 7-nitroindazole, wortmannin and indomethacin on ethanol-induced relaxation of endothelium-intact (E+) and denuded (E−) aortic rings. Concen-
tration–response curves for ethanol were determined in endothelium-intact or denuded aortic rings in the absence or after 30-min incubation with L-NAME (100 μmol/L), ODQ
(1 μmol/L), 7-nitroindazole (100 μmol/L), wortmannin (0.5 μmol/L) and indomethacin (10 μmol/L). ⁎Compared to the respective control group (Pb0.05; ANOVA followed by New-
man–Keuls multiple comparison test).
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Keuls multiple comparison test. Pb0.05 was considered as statistically
signiﬁcant.
3. Results
3.1. Effects of ethanol on vascular reactivity
In endothelium-intact or endothelium-denuded rat aortic rings,
phenylephrine induced sustained contraction, which lasted at least
90 min without any predominant decrease in tension (data not
shown). The addition of ethanol in concentrations ranging from 0.03
to 200 mmol/L caused a concentration-dependent relaxation of
endothelium-intact (Emax: 39.0±2.2%; pD2: 3.1±0.2, n=8) and de-
nuded (Emax: 40.5±2.4%, pD2: 2.8±0.3, n=8) aortic rings (Fig. 1).
The maximum relaxant effect was obtained with ethanol 200 mmol/L.
When the subsequent concentration of ethanol (300 mmol/L) was
added no relaxationwas observed. Instead, at this concentration ethanol
induced contraction of endothelium-intact or denuded aortas (data not
shown). No differences were found between the pre-contractile levels
induced by phenylephrine in endothelium-intact (1.0±0.09 g, n=8)
and endothelium-denuded rings (1.1±0.13 g, n=8).
The relaxation induced by acetylcholine in endothelium-intact
rings was signiﬁcantly different (Emax: 97.8±1.3%; pD2: 7.0±0.2,
n=5) from that found for ethanol (Emax: 39.0±2.2%; pD2: 3.1±0.2,
n=8) (Pb0.05, Student's t test). Similarly, SNP-induced relaxation
of endothelium-denuded rings (Emax: 100.7±4.2%; pD2: 8.3±0.1,
n=5) was signiﬁcantly different from that found for ethanol (Emax:
40.5±2.4%, pD2: 2.8±0.3, n=8) (Pb0.05, Student's t test).
To investigate the mechanisms underlying ethanol-induced relaxa-
tion, endothelium-intact or endothelium-denuded rings were exposed
to NO–cGMP, cyclooxygenase pathway inhibitors and O2−/H2O2 scaven-
gers. L-NAME, 7-nitroindazole and ODQ reduced the relaxation induced
by ethanol in endothelium-intact and denuded rings. On the other
hand,wortmannin and indomethacin did not affect ethanol-induced re-
laxation in both endothelium-intact and -denuded rings (Fig. 2,
Table 1). The participation of K+ channels on ethanol-induced relaxa-
tionwas evaluated using selective K+ channels blockers. Glibenclamide
and 4-aminopyridine, but not apamin or charybdotoxin, reduced
ethanol-induced relaxation (Fig. 3, Table 1). Tiron and catalase reduced
ethanol-induced relaxation to a similar extent. Combination of these
two compounds showed no further suppression on ethanol-induced re-
laxation (Fig. 4, Table 2). Combination of L-NAME and tiron or L-NAME
and catalase showed no further suppression on ethanol-induced
Table 1
Effect of L-NAME, ODQ, 7-nitroindazole, wortmannin, indomethacin, apamin, glibencla-
mide, charybdotoxin and 4-aminopyridine on ethanol-induced relaxation in
endothelium-intact or endothelium-denuded rat aortic rings.
Group Endothelium-intact Endothelium-denuded
Emax
(% relaxation)
pD2 Emax
(% relaxation)
pD2
Control 39.0±2.2 (8) 3.1±0.2 40.5±2.4 (8) 2.8±0.3
L-NAME 100 μmol/L 19.0±1.5 (6)⁎ 2.9±0.2 21.7±2.7 (7)⁎ 2.8±0.2
ODQ 1 μmol/L 17.6±1.4 (8)⁎ 3.0±0.2 20.7±2.2 (6)⁎ 2.7±0.2
7-nitroindazole
100 μmol/L
26.4±2.3 (7)⁎ 2.9±0.2 30.2±2.9 (7)⁎ 2.7±0.3
Wortmannin 0.5 μmol/L 43.8±5.0 (8) 3.3±0.3 44.5±4.5 (6) 3.4±0.5
Indomethacin 10 μmol/L 32.0±4.0 (6) 2.6±0.2 37.3±2.1 (8) 2.7±0.1
Apamin 1 μmol/L 45.4±3.9 (7) 2.9±0.2 38.9±5.6 (6) 2.6±0.1
Glibenclamide 3 μmol/L 27.8±4.3 (4)⁎ 3.2±0.2 21.7±3.3 (6)⁎ 3.0±0.1
Charybdotoxin
0.1 μmol/L
49.2±1.5 (5) 2.7±0.1 42.1±2.7 (6) 2.7±0.2
4-aminopyridine
1 mmol/L
23.6±4.9 (6)⁎ 3.4±0.2 25.4±2.1 (5)⁎ 2.9±0.3
Data are represented as mean±SEM. Number of experiments is indicated between
parentheses.
⁎ Compared to respective control group (Pb0.05; ANOVA followed by Newman–
Keuls multiple comparison test).
Fig. 3. Effect of apamin, glibenclamide, charybdotoxin and 4-aminopyridine on ethanol-induced relaxation of endothelium-intact (E+) and denuded (E−) aortic rings. Concentration–
response curves for ethanol were determined in endothelium-intact or denuded aortic rings in the absence or after 30-min incubationwith apamin (1 μmol/L), glibenclamide (3 μmol/L),
charybdotoxin (0.1 μmol/L) and 4-aminopyridine (1 mmol/L). ⁎Compared to the respective control group (Pb0.05; ANOVA followed by Newman–Keuls multiple comparison test).
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relaxation when compared to the effects of these drugs when added
alone (Fig. 4, Table 2). Finally, 4-methylpyrazole and prodifen, but not
apocynin, reduced the relaxation induced by ethanol (Fig. 5, Table 3).
3.2. Detection of NO in cultured VSMCs
Fig. 6 shows that ethanol induced NO generation in VSMCs. L-NAME
inhibited ethanol-induced NO generation.
3.3. Detection of [Ca2+]c, [NO]c and O2
− in endothelial cells
Fig. 7 shows that ethanol induced an increase in [NO]c and [Ca2+]
c in endothelial cells in a concentration-dependent manner. Similarly,
ethanol induces O2− generation in endothelial cells. Our results show
that the NO production represented as %ΔFI was lower in endothelial
cells pre-treated with tiron, indomethacin, verapamil and L-NAME
(Table 4). Finally, tiron, indomethacin and verapamil attenuated the
increase in [Ca2+]c induced by ethanol in endothelial cells
(Table 4). Ethanol (at the concentrations used), had no signiﬁcant ef-
fect on endothelial cells viability as assessed by trypan blue exclusion
(data not shown).
4. Discussion
Major ﬁndings from the present study demonstrate that ROS scav-
enging or suppression of ethanol metabolism in the aorta prevented
Fig. 4. Effect of tiron, catalase, L-NAME and the combination of these compounds on ethanol-induced relaxation of endothelium-intact (E+) and denuded (E−) rat aortic rings. Concen-
tration–response curves for ethanolwere determined in endothelium-intact or denuded aortic rings in the absence or after 30-min incubationwith tiron (1 mmol/L), catalase (300 U/mL),
L-NAME (100 μmol/L) or the combination of these compounds. ⁎Compared to the respective control group (Pb0.05; ANOVA followed by Newman–Keuls multiple comparison test).
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ethanol-induced relaxation, suggesting that this response is mediat-
ed, in part, by oxidative stress. Moreover, the present data suggest
that ROS generation triggers the activation of the NO–cGMP pathway,
which in turn increases NO generation and relaxation. These ﬁndings
identify redox-sensitive and NO-dependent signaling as novel mech-
anisms underlying ethanol-induced vascular relaxation. It is impor-
tant to note that the concentrations of ethanol used in our study to
evaluate vascular relaxation are relevant since they are within those
found in the bloodstream of humans after moderate ethanol con-
sumption (approximately 5–25 mmol/L) (Klatsky et al., 1992; Thun
et al., 1997; Mukamal et al., 2003). Moreover, in alcoholics, blood eth-
anol level can reach 100 mmol/L.
Ethanol treatment of rat aortic rings resulted in an endothelium-
independent relaxation, which is in accordancewith previous ﬁndings
showing that the relaxation induced by ethanol in vascular tissues is
not solely mediated by the endothelium (Greenberg et al., 1993; Ru
et al., 2008). The relaxation induced by ethanol was approximately
40% of the relaxant response induced by acetylcholine and SNP in
endothelium-intact and denuded rings, respectively. L-NAME and
ODQ attenuated ethanol-induced relaxation in both endothelium-
intact and denuded rings, supporting a role for the NO–cGMP pathway
in this response. Moreover, ATP-sensitive and voltage-dependent K+
channels are also involved in the vasorelaxant response induced by
ethanol. On the other hand, vasodilator prostanoids do not participate
on ethanol induced relaxation since indomethacin did not alter this
response. Our functional results support previous observation demon-
strating that VSMCs produce NO (Kleinert et al., 2004; Carrillo-
Sepúlveda et al., 2010). This ﬁnding, associated with the fact that
ethanol increased NO generation in cultured VSMCs, suggest that re-
laxation of rat aorta in response to ethanol is mediated, at least in
part, by NO generated in VSMCs. In fact, this is the ﬁrst study showing
a direct effect of ethanol in the generation of NO in VSMCs, since cur-
rently available data show that only endothelial cells were previously
identiﬁed as targets for ethanol-induced NO production (Greenberg
et al., 1993; Hendrickson et al., 1999; Kuhlmann et al., 2004). The pres-
ence of eNOS and nNOS in VSMCs was previously described in the cy-
toplasm of these cells under basal conditions (Carrillo-Sepúlveda
et al., 2010). Our data showed that inhibition of nNOS signiﬁcantly re-
duced the relaxation induced by ethanol, showing that nNOS play a
signiﬁcant role in ethanol-induced NO production by VSMCs. This
ﬁnding is consistent with the study of El-Mas et al. (2009), which
demonstrated that ethanol increases NO production in the myocardi-
um by a mechanism that involves nNOS activation via the PI3K/Akt/
nNOS signaling pathway. Interestingly, our data rule out the participa-
tion of the PI3K pathway in ethanol-induced relaxation since this re-
sponse was not attenuated by wortmannin.
Our functional results showed that antioxidant treatment of
endothelium-intact or denuded aortic rings prevented ethanol-induced
Fig. 5. Effect of 4-methylpyrazole, prodifen and apocynin on ethanol-induced relaxation of endothelium-intact (E+) and denuded (E−) aortic rings. Concentration–response
curves for ethanol were determined in endothelium-intact or denuded aortic rings in the absence or after 30-min incubation with 4-methylpyrazole (100 μmol/L), prodifen
(10 μmol/L), apocynin (100 μmol/L) or the combination of these compounds. ⁎Compared to the respective control group (Pb0.05; ANOVA followed by Newman–Keuls multiple
comparison test).
Table 2
Effect of tiron, catalase, L-NAME and the combination of these inhibitors on ethanol-
induced relaxation in endothelium-intact or endothelium-denuded rat aortic rings.
Group Endothelium-intact Endothelium-denuded
Emax
(% relaxation)
pD2 Emax
(% relaxation)
pD2
Control 39.0±2.2 (8) 3.1±0.2 40.5±2.4 (8) 2.8±0.3
Tiron 1 mmol/L 18.4±3.8 (6)⁎ 2.8±0.4 23.1±2.2 (8)⁎ 2.5±0.2
Catalase 300 units/mL 28.6±3.6 (6)⁎ 3.2±0.2 27.5±1.4 (7)⁎ 2.6±0.2
Tiron+Catalase 29.1±4.8 (6)⁎ 3.3±0.5 27.9±3.4(6)⁎ 3.1±0.3
L-NAME 100 μmol/L 19.0±1.5 (6)⁎ 2.9±0.2 21.7±2.7 (7)⁎ 2.8±0.2
Tiron+L-NAME 23.5±3.7 (6)⁎ 3.6±0.3 26.8±2.1 (5)⁎ 3.4±0.2
Catalase+L-NAME 25.2±2.1 (6)⁎ 3.2±0.2 23.3±3.8 (4)⁎ 3.6±0.3
Data are represented as mean±SEM. Number of experiments is indicated between
parentheses.
⁎ Compared to respective control group (Pb0.05; ANOVA followed by Newman–
Keuls multiple comparison test).
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relaxation, suggesting that this response ismediated, in part, by oxidative
stress. In fact, low levels of O2− contribute to vasodilatation particularly
after dismutation toH2O2 (Wei et al., 1996).We have previously demon-
strated that ethanol at 100 mmol/L increases the generation of O2− and
H2O2 in cultured aortic smooth muscle cells (Yogi et al., 2010). Thus,
the ethanol-induced relaxation here described is dependent on ROS
generation by the vasculature. Interestingly, the association of ROS
scavengers with L-NAME showed no additional inhibitory effect on
the relaxation induced by ethanol, suggesting that ROS generation
is the trigger for NO production. This result is consistent with those
reported in the literature showing that O2− enhances Ca2+/NO sig-
naling (Graier et al., 1996) and induces vasorelaxation (Duarte et
al., 2004). Moreover, H2O2 was also described to play a positive
role in regulating NO signaling. In endothelial cells, H2O2 activates
eNOS (Thomas et al., 2001) and the generation of H2O2 has been im-
plicated as a mediator of ﬂow-induced vasodilatation in coronary
and cerebral vessels (Barlow and White, 1998a, 1998b; Miura et al.,
2003). More recently, Kumar et al. (2010) demonstrated that H2O2
increases eNOS phosphorylation and NO generation in pulmonary
arterial endothelial cells. It should also be noted that ROS scavengers
and L-NAME combined did not completely abolish ethanol-induced re-
laxation, indicating that this response may involve other factors and/or
activation of pathways that are not associated with ROS generation or
NO–cGMP pathway.
In order to determine the sources of O2− implicated in the vascular
action of ethanol, the effect of ethanol-metabolizing enzyme inhibi-
tors was tested. ADH and CYP-2E1 are ethanol-metabolizing enzymes
that are functionally active in the vasculature, and ethanol metabo-
lism in this tissue leads to oxidative stress and generation of ROS
(Haorah et al., 2005). We found that inhibition of ethanol metabolism
by ADH strongly inhibited ethanol-induced relaxation while CYP-2E1
inhibition by prodifen attenuated this response. The lack of effect of
apocynin on the vascular relaxation induced by ethanol. ruled out
Fig. 6. Effect of ethanol on NO generation in VSMCs. VSMCs were loaded with DAF-2 FM and exposed to ethanol (100 mmol/L), in the absence or presence of L-NAME (100 μmol/L).
A: representative ﬂuorescence images of VSMCs in basal conditions and in cells stimulated with ethanol in the absence and presence of L-NAME. B: bar graphs demonstrate NO
generation in VSMCs. Data are presented as DAF-2 FM ﬂuorescence (excitation/emission — 495/515 nm). Data are means±SEM of 4 experiments. ⁎Compared to basal (Pb0.05;
ANOVA followed by Newman–Keuls multiple comparison test).
Table 3
Effect of 4-methylpyrazole, prodifen, apocynin or the combination of these inhibitors
on ethanol-induced relaxation in endothelium-intact or endothelium-denuded rat aor-
tic rings.
Group Endothelium-intact Endothelium-denuded
Emax
(% relaxation)
pD2 Emax
(% relaxation)
pD2
Control 39.0±2.2 (8) 3.1±0.2 40.5±2.4 (8) 2.8±0.3
4-methylpyrazole
10 μmol/L
7.2±2.1 (4)⁎ _ 8.8±2.5 (4)⁎ –
Prodifen 10 μmol/L 27.3±2.9 (8)⁎ 3.6±0.2 29.2±2.8 (6)⁎ 3.1±0.3
4-methylpyrazole
+Prodifen
5.2±1.3 (6)⁎ _ 6.0±2.1 (5)⁎ –
Apocynin 100 μmol/L 37.9±5.1 (6) 3.6±0.2 39.2±5.8 (6) 3.2±0.2
Data are represented as mean±SEM. Number of experiments is indicated between
parentheses.
⁎ Compared to respective control group (Pb0.05; ANOVA followed by Newman–
Keuls multiple comparison test).
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the involvement of NADPH oxidases as a source of O2−. Thus, we pre-
sent evidence that ethanol metabolism by ADH and CYP2E1 in the
vasculature is a source for ROS generation, which acts as a signaling
molecule to induce relaxation.
The fact that ethanol-induced relaxation of isolated aorta is
endothelium-independent does not rule out a possible effect of etha-
nol on endothelial cells. Endothelial NO synthesis was directly mea-
sured with DAF-2/DA ﬂuorescence. Our data demonstrate a dose-
dependent effect of ethanol on endothelial NO production. This data
are consistent with the ﬁndings of Acevedo et al. (2001), which dem-
onstrated an ethanol-induced dose-dependent increase of NO pro-
duction in endothelial cells from human umbilical vein. In cultured
bovine aortic endothelial cells ethanol (0.8–160 mmol/L) was
shown to increase eNOS activity (Hendrickson et al., 1999). In our
study, endothelial NO production stimulated by ethanol was sensitive
to L-NAME further implicating the activation of eNOS in this response.
These ﬁndings indicate a possible beneﬁcial effect of low-dose etha-
nol on endothelial function since NO plays a crucial role in vasodilata-
tion, regional blood ﬂow increase, hypotension and atherosclerosis
prevention (Moncada and Higgs, 1991). However, we must be
aware of the fact that ethanol-induced generation of NO was reduced
in the presence of tiron, further suggesting a role for O2− in this re-
sponse. Moreover we found that ethanol induced O2− generation in
endothelial cells, which is involved in the ethanol-induced increase
in [Ca2+]c. Studies in endothelial cells have shown that O2− induces
a rapid rise in [Ca2+]c (Franceschi et al., 1990; Dreher and Junot,
1995; Hirosumi et al., 1988), which might activate eNOS with conse-
quent vasorelaxation (Duarte et al., 2004). Ca2+ is required for the
activation of eNOS. Our data show that verapamil partially inhibited
ethanol-induced NO generation in endothelial cells. Recently, we pro-
vided evidence that ethanol induced an increase of [Ca2+]c in aortic
smooth muscle cells and that this response is attenuated by ROS scav-
engers and cyclooxygenase inhibitors (Yogi et al., 2010). Similar re-
sults are described in the present investigation in endothelial cells
where ethanol stimulated O2− generation. The latter, may lead to pro-
duction of prostanoids that induce increase on [Ca2+]c. However, it is
important to note that although indomethacin reduced NO genera-
tion in endothelial cells, this cyclooxygenase inhibitor did not affect
the relaxation induced by ethanol in the isolated aorta. A possible ex-
planation for such observation is that the relaxation induced by etha-
nol is partially, but not totally, dependent on the NO generated in
endothelial cells. As mentioned before, relaxation of rat aorta in re-
sponse to ethanol is also mediated by NO generated in VSMCs.
Taken together our ﬁndings support a key role for O2− in ethanol-
induced NO generation in endothelial cells.
The major new ﬁnding of this work is that ethanol induces relaxa-
tion via redox-sensitive and NO–cGMP-dependent pathways through
direct effects onROSproduction andNO signaling. At pharmacologically
relevant concentrations, ethanol induces vascular relaxation by acting
in both endothelial cells and VSMCs. The vasodilator effect is mediated
by increased production of NO, which occurs rapidly by the activation
of constitutive NOS. Ethanol metabolism in the vasculature is possibly
the main source of ROS generation, which acts as a signaling molecule
that triggers the vascular production of NOwith consequent relaxation.
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